FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bernard Gout

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Occupations

Electrophysiology

Anatomy

Hearts

Physiology

Co-author Network

Publications

TOP 3
Jerome Kalifa; M Bernard; Bernard Gout; Antoine Bril; Dragos Cozma; P Laurent; T Chalvidan; Jean-Claude Deharo; Pierre Djiane; P Cozzone; Jean-Michel Maixent
Anti-arrhythmic effects of I (Na), I (Kr), and combined I (Kr)-I (CaL) blockade in an experimental model of acute stretch-related atrial fibrillation.
David Mazurais; Philippe Robert; Bernard Gout; Isabelle Berrebi-Bertrand; Marie Paule Laville; Thierry Calmels
Cell type-specific localization of human cardiac S1P receptors.
Michel Souchet; Elodie Portales-Casamar; David Mazurais; Susanne Schmidt; Isabelle Léger; Jean-Luc Javré; Philippe Robert; Isabelle Berrebi-Bertrand; Antoine Bril; Bernard Gout; Anne Debant; Thierry P G Calmels
Human p63RhoGEF, a novel RhoA-specific guanine nucleotide exchange factor, is localized in cardiac sarcomere.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bernard Gout (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Jerome Kalifa; M Bernard; Bernard Gout; Antoine Bril; Dragos Cozma; P Laurent; T Chalvidan; Jean-Claude Deharo; Pierre Djiane; P Cozzone; Jean-Michel Maixent
Anti-arrhythmic effects of I (Na), I (Kr), and combined I (Kr)-I (CaL) blockade in an experimental model of acute stretch-related atrial fibrillation.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2007;21(1):47-53.
2002: David Mazurais; Philippe Robert; Bernard Gout; Isabelle Berrebi-Bertrand; Marie Paule Laville; Thierry Calmels
Cell type-specific localization of human cardiac S1P receptors.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2002;50(5):661-70.
2002: Michel Souchet; Elodie Portales-Casamar; David Mazurais; Susanne Schmidt; Isabelle Léger; Jean-Luc Javré; Philippe Robert; Isabelle Berrebi-Bertrand; Antoine Bril; Bernard Gout; Anne Debant; Thierry P G Calmels
Human p63RhoGEF, a novel RhoA-specific guanine nucleotide exchange factor, is localized in cardiac sarcomere.
Journal of cell science 2002;115(Pt 3):629-40.
2001: Patrick Pladys; Bernard Gout; Pierre Maison-Blanche; Antoine Bril; Philippe Coumel; François Carré
Influence of atenolol on the kinetics of RT interval rate adaptation in conscious dogs.
Journal of cardiovascular pharmacology 2001;38(1):1-10.
2001: Nambi Aiyar; Robert A Daines; Jyoti Disa; PA Chambers; Charles F Sauermelch; M Quiniou; N Khandoudi; Bernard Gout; Stephen Douglas; Robert N Willette
Pharmacology of SB-273779, a nonpeptide calcitonin gene-related peptide 1 receptor antagonist.
The Journal of pharmacology and experimental therapeutics 2001;296(3):768-75.
2001: Anne M Romanic; Cynthia L Burns-Kurtis; Bernard Gout; Isabelle Berrebi-Bertrand; Eliot ohlstein
Matrix metalloproteinase expression in cardiac myocytes following myocardial infarction in the rabbit.
Life sciences 2001;68(7):799-814.
2000: Patrick Pladys; Pierre Maison-Blanche; Bernard Gout; Fabio Badilini; Antoine Bril; François Carré
Influence of sympathetic heart rate modulation on RT interval rate adaptation in conscious dogs.
Pacing and clinical electrophysiology : PACE 2000;23(11 Pt 1):1604-10.
2000: D Ashton; P Hieble; Bernard Gout; Nambi Aiyar
Vasodilatory effect of adrenomedullin in mouse aorta.
Pharmacology 2000;61(2):101-5.
2000: Frédéric Victor; François Carré; Bernard Gout; J Jean; E M'Polesha; Philippe Mabo; Antoine Bril
Cardiac loading conditions modify the ventricular repolarization in conscious dogs with heart failure.
Pflügers Archiv : European journal of physiology 2000;439(3):217-26.
1999: JF Faivre; MC Forest; Bernard Gout; Antoine Bril
Electrophysiological characterization of BRL-32872 in canine Purkinje fiber and ventricular muscle. Effect on early after-depolarizations and repolarization dispersion.
European journal of pharmacology 1999;383(2):215-22.
1999: Bernard Gout; M J Quiniou; N Khandoudi; C Le Dantec; B Saïag
Impaired endothelium-dependent relaxation by adrenomedullin in monocrotaline-treated rat arteries.
European journal of pharmacology 1999;380(1):23-30.
1999: K Dang; Jyoti Disa; Bernard Gout; Nambi Aiyar
Comparative affinities of adrenomedullin (AM) and calcitonin gene-related peptide (CGRP) for [125I] AM and [125I] CGRP specific binding sites in porcine tissues.
Journal of receptor and signal transduction research 1999;19(5):803-17.
1998: G Nadler; JF Faivre; MC Forest; B Cheval; M Martin; Michel Souchet; Bernard Gout; Antoine Bril
Synthesis, electrophysiological properties and analysis of structural requirements of a novel class of antiarrhythmic agents with potassium and calcium channel blocking properties.
Bioorganic & medicinal chemistry 1998;6(11):1993-2011.
1996: Antoine Bril; Bernard Gout; M Bonhomme; L Landais; JF Faivre; P Linee; R H Poyser; R R Ruffolo
Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
The Journal of pharmacology and experimental therapeutics 1996;276(2):637-46.
1995: Bernard Gout; A J Nichols; G Z Feuerstein; Antoine Bril
Antifibrillatory effects of BRL-32872 in anesthetized Yucatan minipigs with regional myocardial ischemia.
Journal of cardiovascular pharmacology 1995;26(4):636-44.
1995: Antoine Bril; JF Faivre; M C Forest; B Cheval; Bernard Gout; P Linée; R R Ruffolo; R H Poyser
Electrophysiological effect of BRL-32872, a novel antiarrhythmic agent with potassium and calcium channel blocking properties, in guinea pig cardiac isolated preparations.
The Journal of pharmacology and experimental therapeutics 1995;273(3):1264-72.
1994: Antoine Bril; M C Forest; B Cheval; L Landais; Bernard Gout
Effect of zatebradine, a specific bradycardic agent, on ischemia-induced arrhythmias in anesthetized rabbits.
Pharmacology 1994;48(5):308-19.
1993: Antoine Bril; L Landais; Bernard Gout
Actions and interactions of E-4031 and tedisamil on reperfusion-induced arrhythmias and QT interval in rat in vivo.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1993;7(2):233-40.
1992: Antoine Bril; M P Laville; Bernard Gout
Effects of glibenclamide on ventricular arrhythmias and cardiac function in ischaemia and reperfusion in isolated rat heart.
Cardiovascular research 1992;26(11):1069-76.
1992: Bernard Gout; J Jean; Antoine Bril
Comparative effects of a potassium channel blocking drug, UK-68,798, and a specific bradycardic agent, UL-FS 49, on exercise-induced ischemia in the dog: significance of diastolic time on ischemic cardiac function.
The Journal of pharmacology and experimental therapeutics 1992;262(3):987-94.
1991: Antoine Bril; M C Forest; Bernard Gout
Ischemia and reperfusion-induced arrhythmias in rabbits with chronic heart failure.
The American journal of physiology 1991;261(2 Pt 2):H301-7.